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Keratin K17, the myoepithelial keratin, is expressed 
in psoriasis but is not present in healthy skin. Psori-
asis is associated with production of y interferon 
(IFNy), which induces the expression of keratin K17 
by activating transcription factor STAT1. Our hy-
pothesis states that the induction ofK17 is specific for 
the inflammatory reactions associated with high lev-
els of IFNl' and activation of STAT1. One of the 
corollaries of the hypothesis is that the STAT1-acti-
vating cytokines should induce the expression of 
keratin K17, whereas those cytokines that work 
through other mechanisms should not. Furthermore, 
because the STAT activation pathway is dependent 
upon protein phosphorylation events, phosphoryla-
tion inhibitors should attenuate the induction of 
keratin K17, whereas protein phosphatase inhibitors 
should augment it. To test this hypothesis, we ana-
lyzed lesiona1 saDlples of inflammatory diseases using 
in:ununofluorescence, transfected keratinocytes with 
K17 gene promoter DNAs in the presence of various 
I nflammatory reactions result in an influx of inflammatory cells into the site of tissue damage (Olljer, 1992). The types of lymphocytes in inflammatory infiltrates diffe r according to the ca use of inflammation (Ferrick el tI /, 1995). Murine CD4+ T lymphocytes can be divided into two subclasses, 
based o n the pattern of cytokines released after antigenic stimula-
tion (Mosmann and Coffillan, 1989; Rivas and Ullrich, 1992). Th- l 
cells secrete interferony (IFNy), Iymphotoxin, and interleukin-2 
(fL- 2), whereas Th-2 cells produce IL-4, IL-5 , and IL-I0 . Conse-
q u e ntly, Th-l cells are more active in providing help for celluhlr 
immune reactions, whereas Th-2 ce lls are more efficient in sup-
porting humoral immune reactions. In addition, these two types 
inhibit each other during the immune response (Rivas and Ullrich, 
1992; Kamogawa el tI/, 1993) . Similar subsets ofCD4+ TceJls have 
been described in the human immune system, although most 
human T lymphocytes show a Th-O-type profile, with character-
istics of both Th-l and Th-2 cell types (Romagnani, 1991). 
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cytokines, and followed nuclear translocation of 
STAT1 in keratinocytes using specific antibodies. 
Confirming the hypothesis, we found that K17 is 
induced in psoriasis and dermatitis caused by delayed 
type hypersensitivity, which are associated with 
high levels of IFNy, but not in samples of atopic 
dermatitis, which is not. Two cytokines, interleu-
kin-6 and leukemia inhibitory factor, which can in-
duce phosphorylation of STAT1, can also induce K17 
expression, whereas interleukin-3, interleukin-4, in-
terleukin-10, and granulocyte macrophage colony 
stimulating factor have no effect on K17 expression. 
As expected, staurosporine and genistein inhibited, 
whereas okadaic acid augDlented, the induction of 
K17 by IFNI'. Our data indicate that in inflammatory 
skin diseases, lymphocytes, through the cytokines 
they produce, differently regulate not only each 
other, but also keratin gene expression in epidermis, 
one of their target tissues. Key IIIOl'ds: C)'tokilles/DNA/ 
illteifel'ol/./p,'olllotel'. ] lIwest DevIIIQ.to/ 107:569-575, 1996 
The pathogen es is of psoriasis vulgaris is associated with IFN y 
secreting Th-l-Iike lymphocytes (Schlaak el at, 1994). IFNy en-
hances inflammatory processes and has been implicated in the 
pathoge nes is of other types of dermatitis, including delayed type 
hypersensitivity and lichen planus (Barker and MacDonald. 1992; 
C hu el tI /, 1992; Groves el tI /, 1993). In contrast to psoriasis , atopic 
dermati tis is reported to involve Th-2-like lymphocytes secreting 
IL-4 and IL-10 . Accordingly, although atopic dermatitis is a rather 
heterogeneous disorde r, therapeutic use of IFNy seems to be quite 
effective in its treatment (Hanifin el tI/, 1993; Reinhold el 11/, 1993; 
Hamid el tI/, 1994; Viac el tI/, 1994). 
Perhaps the best studied paradigm for a signal transduction 
pathway is that oflFNy (reviewed by Shuai, 1994). Upon binding 
to the ligand, the IFNy receptor associates with cell membrane-
bound tyrosine kinases of the Jak/Tyk family, which cause phos-
phorylation of ST AT transcription f.,ctors, whjch are thus activated 
and translocate to the nucle us. Tn the nucleus, STA Ts recognize 
and bind to specific DNA sequences and interact with the tran-
scription machinery to regulate transcription of specific genes 
(Damell el tI/ , 1994). The regulatol)I specificity of the cytokin e 
signal at the cell surf.,ce is mirrored in the nucleus by the activation 
ofa specific member of the STAT family. For example, STAT1 is 
activated by IFNy, epidermal growth factor (EGF), and IL-6; 
STAT2 (P113) by IFNa; STAT3 by EGF and IL-6 ; STAT5 by 
prolactin; and STAT6 by IL-4 (Fu and Zhang, 1993; GouiJJeux cl tI/, 
1994; Hou el ai, 1994; Schindle r el tI /, 1994; Wakao el 11/, 1994). 
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We h ave show n previously that delayed type hyper sen sitivity 
reactions r esult in activa tion and nuclear trans location of STAT 1 in 
human keratinocytes ;11 V;1I0 and in subsequ e nt induction of tran-
scription o f keratin K17 Oi an g el ai, 1993 ) . Within the promote r of 
th e K17 gen e, we h ave ide ntifi ed and characte rized two sites that 
confe r th e responsiveness to IFNI', o ne of which binds STAT1. 
N o rmal adu lt e pidermis, however , d oes n ot contain K17 (de J o ng 
el ai, 1 991). Keratin K17 is expressed in myoepithe li a l cells, in b asa l 
laye rs of tra n sitiona l and p se udostratifie d e pithe li a of respiratory 
and urinal'y tra c ts, and during earl y d evelo pme ntal stages of 
stratifi e d epith e lia (Troyanovsky ct ai , 1992) . 
Keratins h ave been use d as marke rs of phe n otyp e of epithe lia l 
cell s (O'Guin el nl, 1987). Basal cell s produce k e ratins K5 and K14, 
differen tiating nonkeratini zin g epithelia K4 a nd K13, cornea K3 
and K12, e pide rmis Kl and KIO, palmop lanta r ke ra tinocytes K2 
and K9, and simple epithel ia K8 and K18, w h e reas hair and n ails 
contain their own, " h ard " keratins. In pathologic conditio n s, su ch 
as inflammation , n eoplasm s, an d wound h ealing, additiona l k e ratins 
are expressed , such as K6, K1 6, and K17 . Whereas K6 and K16 are 
associated w ith activated, mig ratory keratinocytes, K17 is found in 
contractilc epithe lia . If th e function of keratin cytoskele ta l n etwork 
is to provide m ech anica l str e n gth , then K6 and K16 keratins may 
m o di fY th e cytoskeleton e nabling the celJ to migrate, whereas K17 
a ll ows it to becom c contractile. The con tractili ty in w o und h ea ling 
is important, but its ro le in inflammatory processes is not clear. 
Our h ypoth esis states that the induction of K17 proceeds via 
activation of ST AT1 tran scriptio n factor. Con seque ntly , a ll 
STAT1 - activatin g cytokin es should indu ce th e expression ofkera-
tin Kl 7, and those cytoki n es th at work through other m echanism s 
sh o uld n ot. 
O ur hypoth es is is supporte d by the evide n ce presente d h e re that 
K17 is induced strongly and specifica ll y b y IFNI', a produc t ofTh-1 
lymphocytes. In contrast, IL- 4 and IL-1 0 n e ither regulate K17 
transcr ip t io n by th e m selves n or affect the induc tion by I FN 1'. 
Furthermore, inhibitors of tyrosine kinases, su ch as genistein and 
staurosporin e, inhibit K17 induc tio n by IFNI', whereas in hibi tors of 
protein k inase C and inhibi tors of the Ras/m itogen activated 
protein kinase (MAPK) C pathway do not, whi ch indicates th at K17 
induction b y IFNI' d oes n ot invo lve prote in kinase C or Ras/ 
M APK. 
W e a lso sh ow that th e expression o f K17 in human inflammatory 
diseases corre lates with the cytokine profi les in these diseases. For 
exa mple, the les iona l skin from p sori asis or d e layed type h ypersen-
sitivi ty does contain K17, whereas the lesiona l e pide rmi s from 
atopic dermatitis p atie nts does n ot. Our d a ta d escribe at the 
molecul ar le ve l th e m echanisms th at regu late and c hange K1 7 gene 
expressio n in hum an e pidermal keratinocytes ill lIilm as well as in 
human epiderma l di seases ill lJ i llo. 
MATERJALS AND METHODS 
DNA Constructs T he plas mids conta ining keratin promoters and the 
contro l pl asmids pRSVZ have been desc ribed previo usly Oiang e/ a/, 1990, 
1991, 1993). T he pl asmid con ta ining the in tracellular ad hesion molecule 1 
(ICAM-1) promoter was a gift from S. W. Caughm an (Emory University, 
Atlanta, GA). T he plasm id expressing R asDN was obta ined from E. 
Skolnick (New York Unive rsity Medical Center, New York). DNA 
primers were synthes ized on a Gene-Plus synthesizer (Pharmacia, Piscat-
away, NJ) according to their promoter sequences. All D NAs used in 
transfections were purified using the Magic Megapreps DNA purification 
system (Promcga, Madison , WI). 
Cells and Tran sfcetion N ormal human foreski n epidermal keratino-
cytes were a generous gift fi'om Dr. M . Simon (SUNY Stony Drook, Stony 
Drook, NY) . T he cul tures were ini tiated using 3T3 feeder layers as 
described previous ly (Randolph and Simon. 1994) and then frozen in liquid 
N , un ti l used. O nce thawed. the keratinocytes were grown witho ut feeder 
ceils in defi ned se ru m-free ke ratinocyte medium supplemented with epi-
dermal growth factor and bovine pituita ry extract (keratinocyte-serum-free 
medium, GIBCO, Gaithersburg, M D). Cell s were expanded thro ugh two 
1:4 passages befo re transfection and transfected at 80-100% conAuency. 
Transfections usi ng po lybrene with d imethyl sulfoxide shock were 
performed as previo usly described Oiang e/ tI /, 1991) . Each transfection 
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contained 15 /l,g K17CAT per di sh and 3 J.Lg RSVZ per di sh. T he constrUCt 
expressing Ras domin;lI1 t negative m uta n t (15 J.Lg per dish) waS co-
transfected w ith the K17CAT construct in the experiments involving 
Itas/M APK pathway. The ce ll s were then incubated with or w ithout IFNI' 
in conlbinatioll w ith granulocyte 111 acrophagc co lony stillllli ating f.'lctor 
(G M-CS I=), IL-3, IL-6 , IL- 'I 0, leukemia-inhjbi ting filctor (LIF), and various 
kinase and phosphatase inhibitors as indica ted . IFN I', IL-I0 , and LI F were 
from R&D Systems (M inneapo lis. MN); GM-CSF. IL-3. and IL-6 were 
fro m U.D.!. (Lake Plac id , NY) ; cA MP, staurosporine , and gen.istein were 
fi'om Sigma (St. Louis, MO); bisindolylmale imide was from Calbiochem 
(San Diego, CAl; and okadaic ac id was from G LBCO DIU (Gajthersburg, 
MD). T hirty-six to 48 h after transfcction, cells were washed twice with 
phosphate- buffered saline and harvested by sc raping. T he ce ll disruption by 
repeated freeze- thaw cycles, and chloramphenicol acctyl tra nsferase (CAT) 
and J3-ga lactosidase assays have also been described previo usly Oiang e/ a/, 
1990. 1993). A U C AT va lues were norma lized fo r trnnsfection effic iency by 
calculating the ratio of CAT activity to J3-ga lactos idasl! in each transfected 
plate. Each transfection experimcnt was separate ly perfo rm l!d three or more 
times, with each data point resul ti ng fro m duplicate or triplica te transfec-
bOtH. 
Gel Retardation Expcrimcnts Keratinocytcs were grown to confiu-
ency and then treated w ith l OOO U IFNI' pe r ml or 100 ng EGF per ml, or 
left utltreated. After 45 min. cells £i'om two 100-mm d ishes we re harvested 
by scraping. collected by precipi tation, washed with phosphate-buffered 
saline, and resuspended in 100 J.LI of buller conta ining 20 m M N-hydroxy-
ethylp iperazine-N'-2-ethanesul fonic acid (pl-l 7.8), 450 mM NaCl, 0.4 mM 
ethylenediamine tetraacetic acid, 0.5 mM dithiothre ito l, 25'% glycerol , 0.5 
mM phenylmethylsulfonyl Auoride . T he suspension was freeze-thawed four 
times and spun at 4°C to remove debris. Whole ce ll extracts , approximatel)' 
5 J.Lg of prote in , were first incubated 15 min on icc with o r w ithout a 
200-fold molar excess of doub le-stranded DNAs used as unlabeled com-
petito rs in 25 J.LI o f binding buffer containing 20 mM T ri s-HC I, pH 8, 100 
mM N aCl, 5 mM MgCI2' 1 mM dithiothre itol. 0 .1 mM ethylenediamine 
tetraacetic acid, 4 mM spermidine. 10'X, g lycero l, 2'% po lyv inyl alcohol, and 
2 J.Lg o f po ly(d l-dC). 
T he probe was end-labe led usi ng the Klenow fragment and [a_32 PjdCTP, 
50 J.LCi per reaction, and purifIed by gel fi ltration using Sephadex G50 
columns (Chroma-Spin , C lontech, Palo Alto, C Al . O ligonucleotide probe 
(80,000 cpm), be tween I and 10 pg, was then added and incuba ted for 
additiona l 30 min on ice. Probc bound to nuclear prote in was reso lved from 
free probe through a 5% po lyacrylamide gel (acrylamide:bis-acrylamide = 
29: 1). at 120 V fo r 150 l11in . Arte r drying. gc ls were au torad iographed 
overnight at - 70°C on XAR 5 fi lm (Kodak, R ochester, NY) with screen 
in tensifiers. 
Immunohistology All biops ies were taken after obta ining in fo rmed 
consen t fro m patients and laboratory vo lun teers according to the protocols 
'lUtho rized by the New York Uni versity (NY U) Medical Center Institu-
tional R cview 130ard . Four-millimeter punch biopsies werl! taken from 
lesional skin o f duel! adult atopic dermatitis patients, one o f whom waS an 
ac ute erythroderrni c male patient; the other two were fe males with 
recurrent eczem ato us lesions on the Aexor surf.1ce of the ir arms. Four male 
and four fe male pso ri atic patients gave biopsies from their les ional skin. The 
forearms of hea lthy vo lun teers were injected w ith a tuberculos is allergen 
purified prote in derivative skin test. After 48 h , punch biopsies were taken 
fi'om the tuberculosis all ergen purified protein derivative injection site and 
froln an uninjcctcd adjacent site o n each volunteer. Biopsies w e re C111bcd-
ded in T issue Tek OCT compound (Mi les Scientifi c, Elkh'lrt, IN), tTozen in 
liquid ni trogen, and stored at - 70°C. Frozen sections were cut from 4 to 6 
J.Lm. collected onto gelatin-coatcd slides , and sta ined according to standard 
immuno Auoresccnt staining protocol (O'G uin el tI /. 1987). T he primary 
antibody used was CK'17 mo use monoclonal antibody (113L R esearch 
Products, Cambridgc, MA). T he secondary antibody used was anti -mouse 
IgG rhodamine conjugate preabsorbed with human Sl!rum proteins (S igma 
Immu nochem icals, St. Louis , MO). 
Human epidermal keratinocytcs were grown to fourth passage and plated 
on g lass coverslips. T hese were grown fo r 72 h in se rum-£i'ee medium 
(G IBCO), after which the medium was changed to ke ratinocyte basal 
medium and the cell s were incubated fo r another 24 h. T he keratinocytes 
were then treated with IFNI' (1000 U per ml) fo r vary ing lengths of time 
ranging from 1 min to I h and with IL-3 (300 ng pe~ ml) , IL-6 (1000 ng per 
ml ). GM-C SF (500 ng per ml) , or L1 F (100 ng per ml) for 30 mill . T he cells 
were washed twice with phosphate-bullered sa lille fixed w ith methanol : 
ace tone (1 :1) for 5 min , dried . and stored at - 20°C . The coverslips were 
sta illed with the STAT1-specific antibody (g ift fro m Dr. J. Damel.l , 
R ockefeller Unive rsity Medical Center. N ew York) and anti-rabbit IgG 
Auoresce in isothiocyana te-conjugated secondary antibody (Sigma Immuno-
chemica ls). 
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F igure 1. Keratin K17 is not expressed in epidermis from patients 
w ith atopic dermatitis, but is expressed in psoriatic e pidermis and 
del ayed type hypersensitivity reaction sites . J3i opsics we re sectioncd 
and s tained with K1 7 specific antibody. T he pos itio ns of cpidermis (E) and 
derrnis (D) arc marked. Scnle IJn rs. 15 1.l.I n. (n) H ealthy skin. (b) Delayed typc 
hypersensiti vity. (e) Psori atic les io nal skin . (d) Atopic de rmatitis. T Ill! 
find ings prescn tcd arc reprcsentative o f eight psoriatic samples. three wi th 
de layed type hype rsensitivity and three w ith atopic dermatiti s. 
R ES U LTS 
Keratin Kl7 Is expressed in Psoriatic Epidermis but Not in 
Atopic Epidermis He~lthy human in te rfolli cular epidermis does 
not contain K17 keratin, although in th e contractile epi thelia of 
sweat g lands and o ute r root sheet of hair fo llicl es copi o us am ounts 
ofK1 7 are found (Fig lA) . T o determine w he ther K17 is expressed 
in inflamm atory de rmatoses, w e examin ed bio psies fi'o m three adult 
patients with ~topic de rmatitis and three control s. Eight biopsies 
fro m psorias is patients and three w ith tuberculosis all ergen purifi ed 
protein derivative-induced delayed type hypersensitiv ity w ere also 
obta in ed . T hese specim ens w e re secti oned and s t~in ed w ith anti-
K17 antibod y. 
In psoriatic epidermis, K17 wa s fo und thro ug ho ut the cytoplasm 
of suprabasal cell s (de J o ng et nl, 1991; Schlaak et nl, 1994). T he 
basal layers were comple te ly spared and e ve n th first suprabasa l 
layers express mu ch less K17 keratin than the layers abo ve them 
(Fig lC) . In delayed type hypersensitivity, th e staiJling w as also 
exclu sively suprabasal but more patchy, not as hom ogeneous as in 
psoriasis (Fig 1B). In contrast, a to pic de rmati tis was comple te ly 
devoid of K17 keratin (Fig lD) . Although the epidermis w as as 
hypertrophic as in psoriasis, and the basal layer just as convo luted , 
in atopic skin , parakeratosis and keratin K17 are absen t. 
Th-2-Type Cytokines, IL-4 and IL-lO, Did Not Affect the 
K 17 Expression Induced by IFNl' Because we did not detect 
keratin K 17 in lesional skin of atopic dermatitis, where T h-2- type 
cytokines predo minate , w e questi o ned whether those cytokines 
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Figure 2. IL-4 and IL-tO have no effect on the induction of K 17 by 
IFNI" (A) Kerati llocytes werc transfected wi th K17CAT o r ICA M-CAT 
constructs and incubarcd w ith or without IFN I'. IL-4 was added 2 h prio r to 
(fL4 1IFl\~. simul ta ncously w ith (IFN+ IL .J ), o r 2 h aftcr addi tio n of IFN I' 
(IFNI IL4). (B) Keratinocytes were tra llsfec ted with K I7CAT and incuba ted 
w ith o r w itho ut IFN I'. IL-1 0 was added 30 min p rior to addi tion of IFNI'. 
interfe re with th e indu ctio n o f K 17 by IFN I'. T here fo re, we 
tnm sfected plasmid K1 7CA T into primary cul tures of hum an 
epidermal keratinocytes, w hi ch w ere then cul tured in the presence 
or absence of IFN I', i.n combin atio n w ith JL-4 o r IL-l O. W hereas 
IFNI' strong ly induced transcription from the K 17 gene pro m o ter , 
IL-4 by itself did not increase 0 1' d ecrease the transcrip tion of K 17, 
nor did it aff-ect the indu ctio n of K1 7 by IFN I' (Fig 2A ). 
W e examined the e ft'ec t of the tim e of additi on of the two 
cytokines : we added IL- 4 2 h prior to, simultaneously w ith , or 2 h 
after additio n of IFN I'. Both K1 7 and [C AM gene pro m oters were 
exa mined , and the resul ts show tllat th e time of ad di tion of JL-4 has 
no e ffect on either pro m oter (Fig 2A) . 
IL-10 has been reported to activa te STAT1 in certain cell types 
and to induce FCl'lU expressio n as IFN I' does. O n the othe r hand , 
IL-IO is al so kJlown to work ~s an inhibi to r of immune reaction in 
vario us situations. T his pl'Ompted us to investigate w hetll er IL-I O 
can indu ce K17 as IFN I' does 0 1' inhibit the induction of K 17 by 
IFN I'. ExpeJ'iments in Fig 2B show that IL-l 0, like IL- 4, neither 
regulates the expressio n of K17 by itself nor inhibi ts the e ff-ect of 
IFNI'. Ide ntical re sults w ere o btained w hen H eLa cell s were 
transfected : ne ithe r IL- 4 no r IL-l0 a ffected K 17 expressio n in the 
presence o r absence o f IFN I' (data no t shown) . In keratinocytes 
IL- l 0 did no t ca use nuclea r transloca ti on ofSTAT1 (A. Semat and 
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F igure 3. High c oncentra tion o f IL-6 can induce K17 promoter. 
Kerati nocytcs we rc trall sfected w ith K17CAT or KI 6CAT :lIld thcn 
incubated w ith vario us conccn tratio ns of IL-6. T he cxperimcn t was per-
fo rmed w ith two d iffe rcnt batchcs of kc rati nocytes, both ti mcs w ith 
duplicate trallsfcctio ns . 
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Figure 4. GM-CSF and IL-3 have no effect on the induction ofK17. 
GM-CSF or LL-3 was add cd to kcratinocytcs transfcctcd with K17CAT 
alonc or 30 min prior to addition of IFNI'. 
M. Blumenberg, unpubli shed observations). At present we do not 
know whether the lack of efFect by IL-4 and IL-IO in keratinocytes 
is due to the lack of corresponding receptors, compon ents of signal 
transduction cascades, o r other cau ses. 
IL-6 and LIF Can Induce Transcription of the K17 Gene 
Promotor T he cytokin es that share gp130 as the {3 component of 
their receptors, namely IL-6, lL-11, LIF, oncostatin M, and ciliary 
neurotrophic factor, can activate STAT1 in their signal transduction 
(Gearing el ai, 1992; Taga cl ai, 1992). Specifically, a high concen-
tration of IL- 6 h as been reported to ind uce the binding of STAT1 
to the SLE sequ ence in HepG2 cells (Harroch e/ ai, 1994; Yuan e/ ai, 
1994; Z hong e/ ai, 1994). We therefore investigated w hether such 
cytokines can also induce K17 expression in keratinocytes. At high 
concentration (more than 150 ng per ml), IL- 6 was able to induce 
K17 (F.ig 3). As a negative control we transfected a construct 
containing K1.6 keratin gene promoter, w hich responds to EGF but 
not to I FN 'Y. The very high concentration of IL-6 required is 
probably beca use of an insufficient amoun t of the a-subuni t of the 
[L-6 receptor. Ll F was not able to induce K17 in keratinocytes, 
w hich probably do not express LIF receptor in culture . LIF strongly 
indu ced ](17 expression in HeLa cells (data not shown). T hese 
results confirm that those cytokines that can activate the transcrip-
tion factor STAT 1 can induce the expression of keratin ](17. 
GM-CSF, IL-3, IFNa, or IFN/3 Has No Effect on Regulation 
of K1 7 Gene GM-CSF and IL-3 belong to the same cytokine 
family beca use they sh are the same {3-component of their receptors, 
p1 20, d istinct fi'om the gp130 described above (Kitamura ci ai, 
1991). They have been reported to induce a DNA-binding protein 
of 80 leDa that binds to the same GRIt site as STATI and to inhibi t 
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the indu ction of FC'Y1U by [FN 'Y (Lam er el ai, 1993). When we 
tested G M-CSF and IL-3 to determine w hether they inter fe re with 
IFN'Y in induction of K17, w e found that these cytokines neither 
induced K17 expression by themselves nor inhibited the effect of 
IFNI' (Fig 4). We conclude that signal transduction via p120 has no 
effect on induction o f K17 expression . 
T hrough their receptors and Ja k/Tyk kinases, all three interfer-
o ns activate re lated transcription factors; namely, [FNa and IFN{3 
induce ISGF-3, w hereas IFN 'Y indu ces STAT1, one of the subunits 
of ISGF- 3 (Fu el ai, 1992; Lo h cl ai, 1992). IFNa and [FN{3 share a 
common receptor and signaling pathway. We found that neither 
IFN a nor I FN{3 induce ](17 (data not shown) , w hich indicates that 
the induction of K17 by in terferons is specific fo r IFN 'Y. 
The Effect of Inhibitors of Protein Kinascs and Phosphata-
ses 011 the Induction of K17 by IFNI' To evaluate the 
involvem ent of protein kinases in the indu ction of K17 by 1FN'Y, 
after the transfec tion but before adding IFN 'Y, we treated the 
keratinocytes with various kinase inhibitors. Staurosporin e, known 
to inh.ibit most prote in serin e, threon ine, and tyrosin e kinases, as 
well as geniste in , a specific tyrosine kina se inhibitor (Yuan el ai, 
1994), prevented K17 induction by I FN 'Y (Fig 5A,B). O n the other 
h and, bisindolylmaleimide, a specific inhibitor of protein kinase C, 
did not inhibi t induction of K17 expression by IFN'Y (Fig SC) . 
Eq uivalent resul ts were obta ined in HeLa cells, and w e also tested 
the e ffects of geniste in on the induction of lCAM1 and found that 
it can inhibit ICAM1 induction as well (data not shown), confim1-
in g that protein phosphorylation, and m ore specifically tyrosine 
phosphorylation, is an essential component of induction of K17 and 
ICA M-1 expression by 1FN'Y. 
Many signal transduction pathways converge at th e R as pro[Qon-
coprotein (Ullrich and Sch lessinger, 1990) . Ras transmits, for 
example, EGF and plate let-derived growth factor signals to Raf 
prote in kinases, which conduct them furth er to the nucleus. 
Furtherm ore, under certa in conditions EGF can activate STAT1 
(Fu and Z h ang, 1993; Ruff-Jamison ci ai, 1993). Although Jak/Tyk 
signaling in the case of STAT proteins does not direc tly in volve the 
Ras/Raf pathway, it is possible that the two pathways interact and 
modulate the regul ation of K17 gene transcription . T herefore, we 
co-transfected a constru ct expressing a Ras dominant negative 
mutant protein with ](17CAT and found that this mutant had no 
effect on inducti on by IFNI', although it did inhibi t induction of 
K16 by EGF (data not shown). [n addition, because cAMP is known 
to interfere with the Ras/MAP]( pathway by phosphorylating and 
inhibiting protein kinase Raft (Wu cl ai, 1993), we raised the 
intracellular cAMP levels in transfected keratin ocytes before adding 
1FN'Y. T he results showed that raisin g the level of intracellular 
cAMP, while preventing the induction of K16 by EGF, did not 
in terfe re w ith the induction of ](17 by IFN'Y (data not shown) . 
W e also examined the effects of okadaic acid , a protein phos-
phatase in hibitor, which is known to induce, il/ter alia, MAPK 
activation by preventing dephosphorylation of signaling cascade 
prote ins. Okadaic acid alo ne induced ](17 expression and had an 
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Figure 5. Tyrosinc phosphorylation but not protein kinasc C is an cssential con'poncnt of induction of K17 by IFNy. Kcratinoc),tcs were 
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to the STAT! binding site GAS. Gel-shi ft ana lys is of STAT I activation. 
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additive effect on K17 indu ction by lFNy, i.e., caused superinduc-
tion (Fig SD). Apparentl y, dephosphorylation attenuates the IFN y 
signal; therefore, bl ocki ng the deph osphorylation ca n augment the 
induction ofK17 expression by IFN y. 
Taken togethe r, these results suggest tha t the indu ction of K17 
expression proceeds direc tly v ia phosphorylation and activation of 
the STATl transc rip tion hlc tor and does not necessarily in vo lve 
anoth e r signal transduction cascade. 
Activation of STAT1 in Hutnan Epidcrtnal Kcratillocytcs 
To demonstrate activation of STATI in human epide rmal ke rati-
noeytes by IFN y, we used gel shift assays. Whole ce ll extrac ts were 
prepared fi'om untreated keratinocytes and ke rati nocytes treated 
with IFN y o r EGF. T he extracts were added to rndio labe led DNA 
oUgonucleotides that contain e ith er a stro ng STATl binding se-
quence or th e AP1 consensus binding sequence. EGF strong ly and 
specifica ll y activated protein s bindin g to the AP1 consensus, 
whereas IFNy activated bindin g to the STAT1 binding site (Fig 6) . 
Thi s experimen t demonstrates the specifi city in activation of the 
signa l-transducing transcription f.,cto rs. 
Upon stimula tio n by IFN y, STAT] is trans located to the nucleus 
in vario us types of ce ll s. Because keratinocytes arc an impo rtan t 
target of IFNy, and beca use it seems th at I FN y in duces K17 
expression through the STATl pathway, we determined the time 
course for trans location of STAT1 into the nucleus (Fig 7). We 
observed a ve ry weak and dilfuse background sta ining before 
sonlulation. A fte r 1 min of treatment w ith IFN y, the STAT1 
epitope was found mainly in cytop lasm . After 5 min, it started to 
translocate in to the nucl eus . T he in tensity of the signal in the 
nucleus inc reased fo r 30 min and then remained in the nucleus at 
lease until the 60- m in c.imepo inr. T he strong cytop lasmic staining 1 
min afte r stimul ation was probably due to the activation ofSTATl 
protein by ph osphorylation , w hich is subseq uentl y followed by 
trans location to the nucleus . 
We examined next whether IL-6, LlF. G M-CSF, o r IL- 3 causes 
ST A T 1 trans loca ti on to the nucleus (Fig 8) . The ce lls grown o n 
covers lips were exposed to those cytokines for 30 min . T he STAT1 
epitope sh owed weak sta inin g and nuc lear trans location with l L-6 
and LIF, but IL-3 and GM-CSF had no e fiect . These results 
corre late very well w ith the fun c tio nal resul ts fi'o m tra nsfection 
experi m ents. 
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Figure 7. STAT! translocates into the nucleus in a time-dependent 
manner after stimulation by IFNy. /{eratinocytes grown on coverslips 
were exposed to lFNy and stained with STATI-specific antibody. Scale bar, 
15 /.1.111. 
D ISCUSSION 
It has been suggested that the maj ority of infiltrating T lymphocytes 
in psorias is and delayed type hypersensiti vity are T h-1-like, 
w hereas those in atopic dermatitis are T h-2-like (Hamid e/ nl, 1994; 
Schlaak ci nl, 1994). Using iml11unoAuorescent techniques, we have 
NO 
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Figure 8. The effects of IL-6, LIF, IL-3, and GM-CSF on nuclear 
translocation ofSTAT1. The cells grown on covers li ps were exposed to 
the cytokincs for 30 min and then sta incd with STATI-specific antibody. 
Scali' bar. 15 /.1.111. 
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shown that keratin K17 is expressed in les ional psoriatic skin and in 
delayed type hypersensitivity but not in atopic dermatitis . 
We hypothesized that the presence of Kl7 in psoriasis and 
delayed type hypersensitivity is due to the high levels of IFN I' in the 
lesional skin and that its absence in atopic dermatitis is e ith er due to 
low levels of IFNI' or to the inhibitory effects of Th-2-type 
cytokines in the lesional skin . T hu s, we in vestigated whether IL-4 
and IL-I0, Th-2-type cytokines, could affect the induction of K17 
by IFNI' or suppress the expression of K17 by themselves . We 
found that IL-4 and IL-lO neither regulate the ex press ion of Kl7 
nor inhibit the effect of IFNI'. This implies that the absence ofK17 
in atopic demlatitis is du e to low levels of IFN I', rather than to the 
inhibitory effects of IL-4 and IL-lO . 
T he molecu lar mechanism of induction by IFNI' depends on 
activation of STAT1 transcription factor, which is sufficient for 
express ion ofKl7 keratin. G roups of cytokines and growth factors 
often act through a common signa l transduction mechanism, and 
we have tested two such groups, one represented by IL-3 and 
GM-CSF, which act through p1 20, the other by IL-6 and LlF, 
which act through gp130 and activate STAT1. Cytokines that 
activate STA Tl, such as IL-6, also indu ce K17, which may be 
important, e .g. , in ultravio let-induced damage that is associated 
with IL-6 release . T he presence of IL-6 has been demonstrated in 
psoriasis (Grossman el ai, 1989), alth ough IL-6 is p rod uced by many 
cell types, and indeed skin is a major site oflL-6 catabolism (Caste ll 
el ai, 1990). We show that both IL-6 and IFN I' can be inducers of 
keratin K17 ill lIil/O. We note, however, that LlF activated K17 only 
in HeLa cells, and not in keratinocytes, which means that the 
selectivity derives, illier alia, from the repertoire of the receptors and 
sign aling molecules. On the other hand, it is clear that the EGF 
pathway, suggested also to be able to ac tivate ST A Tl (Ruff-
J amison el ai, 1993), does not induce K17 Giang el ai, 1993). Indeed, 
blocking the EGF sign al transduction cascade at R as and Raf 
prote ins had no effect on Kl7 promoter transcription. Furthermore, 
IL-3 and GM-CSF, two cytokines produced by activated keratino-
cytes, as well as the other two members of the interferon f.l mily, 
IFN a and IFNt3, had no effect on K17 expression . This implies that 
the induction of express ion of K17 is a paracrine effect of lympho-
cytes and not a result of autocrine stimulation by keratinocytes. 
T he induction of K17 expression parallels activation of ST AT1 . 
Inhibito rs of protein phosphorylation, particularly tyrosine phos-
phorylation, inhibit induction , whereas inhibitors of dephosphory-
lation augment it. Furthermore, cytokines that promote stron g 
nuclear translocation of STATl strongly induce K17, those that 
cause weak translocation induce weakly, and those that do not 
cause translocation induce not at all. 
Although ill I/i lYO induction of lCAM-l seems stronger than 
induction of K17 (Fig 2), copious amounts of K17 keratin are 
present in psoriasis ill lIillo (Fig 1) . T his may reflect a very lugh 
stabili ty and slow turn over rates of keratin proteins relative to cell 
surface markers. Furthermore, although IFNI' causes the expression 
oflCAMl and HLA-DR markers in aU cell layers (Terui el ai, 1987; 
Lisby cl ai, 1989; Singer ct ai, 1989; Esgleyes-Ribot el ai, 1994), the 
expression of K17 is strictly suprabasal (Fig 1). This refl ects 
rigorous regulation of keratin gene expression: keratins K5 and K14 
are strictly basal, whereas the expression of difFerentiation markers 
K1 and K10, activation markers K6 and K16, and K17 is strictly 
supra basal. T hese keratins are excluded from the basal layer. 
In addition to STAT1, several transcription factors bind to the 
promoter of K17 keratin gene (V. Milisav ljevic el ai, 1996). An 
in terferon-regula tory factor consensus element exists upstream 
fro m the STAT1 bindin g site, but the ro les of additional e lements 
as independent o r accessory transcription factors are no t yet clear. 
For example, K17 keratin protein is a normal constituent of 
contracti le epithe lia, where IFN I' is not ordinarily present. These 
additional transcriptional e lements may also be responsible for 
restricting the expression of K17 prote in to the supra basa l ce lls of 
the epidermis. 
We do not know w hich cytokines, in addition to IFNI', induce 
K17 keratin ill I/il/O. T he post-transcriptiona l events, such as those 
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that affect mRN A and prote in stability, also remain unexplored. 
Perhaps th e most intriguin g question, and a subject of our current 
efForts, is why I FN I' changes the cytoskeleton of keratinocyte by 
inducing synthesis of contractile protein in inflamed epidermis. 
N everth eless, o ur results clearly demonstrate that Th- l and Th-2 
cytokines difFe rently regulate epidermal keratin gen e expression 
and describe the molecular mechanism by which the regulation is 
efFected. T he results demo nstrate a specific alteration of gene 
expression in human disease, a subj ect that, except in oncogenesis, 
h as not been extensively studi ed. 
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